A daily dose of antibiotics helps bacteria develop multi-drug tolerance, according to researchers from KU Leuven, Belgium
Antibiotics cannot easily eradicate the gut bacteria Escherichia coli, as some bacteria survive treatment in a dormant state and once treatment is stopped, these dormant cells can become active again and recolonise the body.
KU Leuven said that its researchers have shown that the more frequently bacteria receive antibiotics, the more of them survive and that these survivors evolved into bacteria with multi-drug tolerance.
Due to the overconsumption and frequent misuse of antibiotics, resistant bacteria are increasingly common, according to KU Leuven, yet even when no resistant bacteria are involved, infections sometimes flare up again after a seemingly successful course of antibiotics.
To examine this phenomenon in detail, scientists from the KU Leuven Centre of Microbial and Plant Genetics treated the gut bacteria Escherichia coli with daily antibiotic doses in the lab.
Even though most bacteria were initially killed, some bacteria found a quick way to adapt with minimal changes in their genetic material, KU Leuven said.
The result was the rapid development of many persister cells. These cells are in a dormant state, and, as a result, are insusceptible to the antibiotic treatment.
These survivors are not resistant – meaning that they cannot continue growing during an antibiotic treatment – but tolerant: they survive the antibiotic treatment and can resume their reproduction after the treatment.
Jan Michiels of the University of KU Leuven, said: “These tolerant cells can just sit out treatment. On the first day of treatment, they are already present, albeit in small numbers.
“They ensure that the population is not wiped out and that it can be reconstituted after the antibiotic treatment. Eventually, you end up with an entire population that is tolerant to several antibiotics.”
KU Leuven said that the research team showed that the number of tolerant cells in a population increases as bacteria are exposed to antibiotics more often: daily doses have a bigger impact than weekly doses, yet the number of cells with multi-drug tolerance decreases again as soon as the antibiotic treatment ends.
Michiels said: “It is common practice to screen for resistance during antibiotic treatments, but not for tolerance. And yet, tolerant bacteria can go on to develop antibiotic resistance, which adds to the global antibiotic crisis: the development of new antibiotics cannot keep pace with the growing antibiotic resistance of bacteria.
“Therefore, figuring out how and why more bacteria develop antibiotic tolerance is important to improve future therapies and thus save lives.”
The KU Leuven team is currently examining whether other pathogens show a similar increase in tolerance and whether the same process of genetic adaptation takes place during the treatment of infections in human beings.